0012 GMT - Mondelez's CEO said the broader snacking category is not diminishing due to consumers' focus on health and wellness. There hasn't been any noticeable decrease in snacking consumption due to GLP-1 medications, either, Dirk Van de Put said. "Since COVID, the indulgence part of snacking is growing just as fast as the healthy part," he said. The snack giant reported a profit of $1.75 billion for the fourth quarter, compared with $950 million a year earlier. (roshan.fernandez@wsj.com)
(END) Dow Jones Newswires
February 04, 2025 19:13 ET (00:13 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.